Biomarkers and Disease Activity in Patients Treated With Teriflunomide (Aubagio)

Condition:   Multiple Sclerosis, Relapsing-Remitting Intervention:   Drug: Teriflunomide Sponsor:   McGill University Recruiting

Source: ClinicalTrials.gov - June 19, 2018 Category: Research Source Type: clinical trials